Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Morphofunctional Heterogeneity and Plasticity of Glioblastoma Cells Induced to Senescence by Temozolomide.

Aging cell·2026
Same author

Temozolomide increases the generation of cell heterogeneity in ERK activity in glioma cells.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

Cellular Morphometric Analysis (CellMorph)-a comprehensive imaging-based tool for quantifying cellular phenotype heterogeneity and dynamics across biological processes.

The FEBS journal·2025
Same author

The states of senescent cells.

Biochemical Society transactions·2025
Same author

Assessing Ecto-5'-Nucleotidase/CD73 Expression and Malignancy Parameters in Early- and Late- Passage C6 Glioma Cells.

Neurochemical research·2025
Same author

Population dynamics is a cancer driver.

Carcinogenesis·2024
Same journal

High-impact Genetic Variants in <i>EGLN1</i>, <i>EPAS1</i>, and Other Genes Identified in Mountaineers by Exome Sequencing.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Review of Potential Diagnostic and Therapeutic Developments in Systemic Lupus Erythematosus (SLE).

Frontiers in bioscience (Scholar edition)·2026
Same journal

The Genetic Feasibility of Gonadal Development and Fertility in Polyodon-Acipenserid Interfamilial Hybrids: An Opinion on the Chromosomal Basis.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Glut1 Acts in Corazonin-Producing Neurons to Regulate Glycogen Storage in <i>Drosophila</i>.

Frontiers in bioscience (Scholar edition)·2026
Same journal

The Evaluation of Neurotrophic Receptor Tyrosine Kinase (NTRK) Alterations in Neuroblastomas.

Frontiers in bioscience (Scholar edition)·2026
Same journal

Molecular Characterization of the Epstein-Barr Virus in Malignant Tumors of Different Origins: An Emphasis on <i>EBER</i> Promoter Value for EBV Classification.

Frontiers in bioscience (Scholar edition)·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Endogenous anticancer mechanisms (EACMs).

Guido Lenz1

  • 1Department of Biophysics and Center of Biotechnology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. lenz@ufrgs.br

Frontiers in Bioscience (Scholar Edition)
|December 29, 2011
PubMed
Summary
This summary is machine-generated.

Cancer cells are common, but deadly disease is rare due to endogenous anticancer mechanisms (EACMs). These evolutionary safeguards, including senescence and immune surveillance, prevent cancer development and offer therapeutic potential.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Related Experiment Videos

Last Updated: May 26, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Area of Science:

  • Oncology
  • Cell Biology
  • Evolutionary Biology

Background:

  • Cancer initiation is common, but progression to lethal disease is rare.
  • Evolution has shaped endogenous anticancer mechanisms (EACMs) to prevent cancer.
  • EACMs safeguard cellular processes from potentially harmful behavior.

Purpose of the Study:

  • To define and present the basic features of key EACMs.
  • To review the role of EACMs in preventing cancer growth.
  • To discuss the importance of EACMs in cancer prevention and therapeutics.

Main Methods:

  • Review of literature on cellular safekeeping mechanisms.
  • Focus on evolutionarily selected processes protecting against cancer.
  • Discussion of specific EACMs: cell senescence, DNA repair, cell cycle control, apoptosis, autophagy, invasion/metastasis blockade, reprogramming blockade, and immune surveillance.

Main Results:

  • EACMs are crucial for detecting and eliminating potential cancer cells.
  • Multiple cellular processes have evolved specific safeguards against cancer.
  • The discussed EACMs play a vital role in preventing cancer progression.

Conclusions:

  • EACMs are fundamental to cancer prevention.
  • Understanding EACMs is critical for developing novel cancer therapeutics.
  • These mechanisms highlight the intricate interplay between evolution and cancer biology.